Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on March 23, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement ...
Olema Pharmaceuticals, Inc. announced the grant of stock options to 11 new employees, allowing them to purchase a total of 322,000 shares of common stock, effective June 2, 2025. This move, approved ...
Replimune Group granted stock options and restricted shares to ten new non-executive employees as part of their incentive plan. Replimune Group, Inc., a clinical stage biotechnology company based in ...
Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 35,200 shares of its common stock to two newly hired employees, ...
BOULDER, Colo., Nov. 12, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new ...
(Nasdaq: MIRM), a leading rare disease company, today announced that on March 11, 2026, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results